Study of Inflammatory and Infection Markers in Periprosthetic Fluid: Correlation with Blood Analysis in Retrospective and Prospective Studies

Table 9

Univariate analysis for the CRP increasing trend.

Covariates	CRP increasing trend ()
	(%)	OR	95% CI	value
Bilateral surgery; Unilateral surgery	1/3 (33%); 9/29 (31%)	1.111	0.089-13-894	0.935
	6/19 (32%); 4/13 (31%)	1.038	0.226-4.768	0.961
	7/15 (47%); 3/17 (18%)	4.083	0.818-20.376	0.086
Smoker; Nonsmoker	4/9 (44%); 6/23 (26%)	2.267	0.453-11.349	0.319
Prophylactic indication; Therapeutic indication	1/4 (25%); 9/28 (32%)	0.704	0.064-7.742	0.774
Total mastectomy; Nipple-skin-sparing mastectomy	5/10 (50%); 5/22 (23%)	3.400	0.693-16.687	0.132
Immediate prosthesis; Expander	0/5 (0%); 10/27 (37%)			0.155
	9/14 (64%); 1/13 (8%)	21.600	2.135-218.579	0.009
	4/10 (40%); 6/17 (35%)	1.222	0.244-6.111	0.807
Contralateral intervention; No contralateral intervention	1/2 (50%); 9/30 (30%)	2.333	0.131-41.554	0.564
Axillary dissection; No axillary dissection	3/6 (50%); 7/26 (27%)	2.714	0.440-16.750	0.282
Previous surgery; No previous surgery	3/11 (27%); 7/21 (33%)	0.750	0.150-3.742	0.726
Chemotherapy; No chemotherapy	2/5 (40%); 8/27 (30%)	1.583	0.221-11.361	0.648
Radiotherapy; No radiotherapy	3/8 (38%); 7/24 (29%)	1.457	0.271-7.821	0.661
	3/13 (23%); 6/18 (33%)	0.600	0.119-3.032	0.537
	5/14 (36%); 5/17 (29%)	1.333	0.294-6.043	0.709

Variables with a value < 0.1 entered the multivariate model.